Cargando…
Effect of Aprotinin and Avifavir(®) Combination Therapy for Moderate COVID-19 Patients
COVID-19 is a contagious multisystem inflammatory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We studied the efficacy of Aprotinin (nonspecific serine proteases inhibitor) in combination with Avifavir(®) or Hydroxychloroquine (HCQ) drugs, which are recommended b...
Autores principales: | Ivashchenko, Andrey A., Azarova, Valeria N., Egorova, Alina N., Karapetian, Ruben N., Kravchenko, Dmitry V., Krivonos, Natalia V., Loginov, Vladimir G., Poyarkov, Stanislav V., Merkulova, Elena A., Rosinkova, Olga S., Savchuk, Nikolay P., Topr, Mikhail A., Simakina, Elena N., Yakubova, Elena V., Ivachtchenko, Alexandre V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310315/ https://www.ncbi.nlm.nih.gov/pubmed/34199134 http://dx.doi.org/10.3390/v13071253 |
Ejemplares similares
-
AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial
por: Ivashchenko, Andrey A, et al.
Publicado: (2020) -
The Efficacy of Aprotinin Combinations with Selected Antiviral Drugs in Mouse Models of Influenza Pneumonia and Coronavirus Infection Caused by SARS-CoV-2
por: Ivashchenko, Andrey A., et al.
Publicado: (2022) -
Aprotinin—Drug against Respiratory Diseases
por: Ivachtchenko, Alexandre V., et al.
Publicado: (2023) -
Biochemical profiling of anti-HIV prodrug Elsulfavirine (Elpida(®)) and its active form VM1500A against a panel of twelve human carbonic anhydrase isoforms
por: Supuran, Claudiu T., et al.
Publicado: (2021) -
FunFun: ITS‐based functional annotator of fungal communities
por: Krivonos, Danil V., et al.
Publicado: (2023)